Illicit Drug use in the Asia Pacific Region - Burnet Institute
Illicit Drug use in the Asia Pacific Region - Burnet Institute
Illicit Drug use in the Asia Pacific Region - Burnet Institute
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Situational analysis of illicit drug issues and responses <strong>in</strong> <strong>the</strong> <strong>Asia</strong>–<strong>Pacific</strong> region<br />
48<br />
2 .9 Myanmar<br />
Population: 42,720,196<br />
2 .9 .1 Overview of<br />
recent drug trends<br />
Opium, hero<strong>in</strong> and amphetam<strong>in</strong>e-type<br />
substances (ATS) are <strong>the</strong> most commonly<br />
<strong>use</strong>d drugs <strong>in</strong> Myanmar . The <strong>use</strong> of cannabis,<br />
code<strong>in</strong>e and tranquillisers has also been<br />
reported but to a lesser extent . Hero<strong>in</strong> <strong>use</strong><br />
predom<strong>in</strong>ates <strong>in</strong> <strong>the</strong> Kach<strong>in</strong> State, Nor<strong>the</strong>rn<br />
Shan State and <strong>in</strong> <strong>the</strong> major cities, while<br />
opium <strong>use</strong> is more common <strong>in</strong> Eastern and<br />
Sou<strong>the</strong>rn Shan State and <strong>in</strong> <strong>the</strong> Kayah State .<br />
Arrest and seizure data suggest that drug <strong>use</strong><br />
is ma<strong>in</strong>ly a male phenomenon .<br />
2 .9 .2 Prevalence of drug <strong>use</strong><br />
There were 62,000 registered drug <strong>use</strong>rs <strong>in</strong><br />
Myanmar <strong>in</strong> 2002; however, this figure is<br />
considered to be a drastic underestimation<br />
of <strong>the</strong> overall number of drug <strong>use</strong>rs <strong>in</strong> <strong>the</strong><br />
country . Estimates of <strong>the</strong> total number<br />
of drug <strong>use</strong>rs <strong>in</strong> Myanmar range between<br />
300,000 and 400,000 people, of which about<br />
140,000 <strong>use</strong> <strong>in</strong>jection as <strong>the</strong>ir preferred<br />
method of adm<strong>in</strong>istration .<br />
In studies <strong>in</strong>volv<strong>in</strong>g school-attend<strong>in</strong>g youth,<br />
about 15 per cent of students reported us<strong>in</strong>g<br />
drugs <strong>in</strong> <strong>the</strong>ir lifetime with non-prescribed<br />
cough medic<strong>in</strong>e (9%), diazepam (4%) and<br />
cannabis (2%) be<strong>in</strong>g <strong>the</strong> most commonly<br />
reported .<br />
There is an overall trend toward <strong>in</strong>creased<br />
drug <strong>use</strong> <strong>in</strong> Myanmar .<br />
2 .9 .3 <strong>Drug</strong> supply<br />
Myanmar is <strong>the</strong> world’s second-largest producer<br />
of opium and is thought to be one<br />
of <strong>the</strong> largest producers of ATS . In 2004,<br />
Myanmar produced 370 metric tonnes<br />
of opium and approximately 700 million<br />
ATS tablets, which corresponds to about<br />
7 .5 per cent of total global manufacture .<br />
Susta<strong>in</strong>ed crop eradication efforts have consistently<br />
reduced <strong>the</strong> overall quantity of opium<br />
produced <strong>in</strong> Myanmar over <strong>the</strong> past 10 years .<br />
Opium cultivation has also been banned by<br />
leaders <strong>in</strong> <strong>the</strong> autonomously controlled special<br />
regions 1 and 2 .<br />
The reduction <strong>in</strong> opium production and disruption<br />
of some drug traffick<strong>in</strong>g groups have<br />
corresponded with a reduction <strong>in</strong> <strong>the</strong> amount<br />
of hero<strong>in</strong> seized recently . ATS production<br />
grew rapidly <strong>in</strong> Myanmar from 1996 with a<br />
peak <strong>in</strong> 2001 . Production is thought to have<br />
rema<strong>in</strong>ed stable s<strong>in</strong>ce <strong>the</strong>n .<br />
2 .9 .4 <strong>Drug</strong>-tak<strong>in</strong>g practices,<br />
risk factors and trends<br />
As opium becomes less available, a number of<br />
new trends are emerg<strong>in</strong>g among drug <strong>use</strong>rs<br />
<strong>in</strong> Myanmar . There is a shift toward ATS and<br />
hero<strong>in</strong> <strong>use</strong> and rapid uptake of <strong>in</strong>ject<strong>in</strong>g<br />
as <strong>the</strong> preferred method of adm<strong>in</strong>istration<br />
for hero<strong>in</strong> .<br />
2 .9 .5 Summary table<br />
The greatest risk associated with IDU <strong>in</strong><br />
Myanmar is HIV . It is estimated that about<br />
30 per cent of all HIV cases <strong>in</strong> Myanmar are<br />
IDUs with HIV prevalence of 50–90 per cent<br />
among this group .<br />
Needle shar<strong>in</strong>g is <strong>the</strong> norm <strong>in</strong> Myanmar .<br />
Factors such as poor access to clean needles<br />
and poor knowledge about HIV lead many<br />
IDUs to share <strong>the</strong>ir <strong>in</strong>ject<strong>in</strong>g equipment .<br />
Estimated number of current drug <strong>use</strong>rs 300,000–400,000 (~140,000 IDUs)<br />
Ma<strong>in</strong> drugs <strong>use</strong>d Hero<strong>in</strong>, opium, methamphetam<strong>in</strong>es,<br />
cannabis, code<strong>in</strong>e and tranquillisers<br />
<strong>Drug</strong>s <strong>in</strong>jected Hero<strong>in</strong>, sometimes mixed<br />
with tranquillisers<br />
Estimated prevalence of<br />
70%<br />
HIV <strong>in</strong>fection among IDUs<br />
49<br />
Country summaries: Myanmar